-
Cole-Parmer Now Offering the NEW Qsonica Q55 Sonicator Ultrasonic Processor
8/22/2011
Conserve lab benchtop space with the new Qsonica Q55 Sonicator Ultrasonic Processor — measuring only eight inches wide and less than eight inches deep.
-
Cole-Parmer Releases the NEW Fluid Handling System Sourcebook 2011
8/10/2011
Laboratory and process solutions from trusted brands such as Masterflex®, Oakton®, Advantec®, Parker®, StableTemp®, and more
-
LECO Corporation Opens A New Separation Science Facility In Europe
8/9/2011
LECO Corporation Opens New Separation Science Facility in Europe
-
Incubators Facilitate Research Under Hypoxic Conditions
6/17/2011
BINDER CB series incubators provide excellent growth conditions for mammalian cell and tissue cultures, offering precise, reproducible control of oxygen concentrations as low as 0.2% and quick recovery times, important factors in conducting research under hypoxic conditions.
-
Wes Wheeler Appointed As CEO By Marken's Board Of Directors
5/27/2011
The Marken Board of Directors is pleased to announce the appointment of Wesley P. Wheeler, MBA as Chief Executive Officer. Mr. Wheeler succeeds Gerard Barba, who will remain the Chairman of the Marken Board of Directors.
-
Marken Announces The Opening Of A Directly Owned Clinical Trial Supply Depot In Singapore
3/8/2011
As part of Marken's continued expansion of services in the APAC region, they have relocated and expanded their Singapore office to further support clients' needs for specialty logistics services
-
GSK And Aptuit Finalize Agreement For Aptuit To Acquire GSK's Research Operations In Italy
7/1/2010
GlaxoSmithKline (GSK) and Aptuit, Inc. announced today that they have finalized an agreement for Aptuit to acquire operations at GSK’s Medicines Research Centre in Verona, Italy.
-
Webinar Announcement: What Early Stage Companies Need To Know About Quality Management: Lessons Learned From Industry Leaders
6/4/2010
Life sciences companies are trying to cope with the mounting challenges of managing and maintaining quality systems while facing increased compliance risks. Clinical trials are becoming more complex and the FDA is scrutinizing data to a higher degree.
-
Reduce Downtime, Lessen Startup Problems While Migrating To A New IBM System i (iSeries)
4/23/2008
The computing load placed on an aging IBM AS/400 model 730 caused response times to swell, so a powerful new IBM System i model 570 was acquired to take its place. All of the healthcare facilities supported by this system operate on a 24/7 basis, with Adventist employees accessing and updating patient charts continuously. A conventional migration from the AS/400 to the new System i model 570 was going to result in an unacceptable amount of downtime— potentially more than 20 hours. Submitted by Vision Solutions
-
The Learning Key Creates The PHARM Game 2
7/20/2007
The Learning Key® developed The PHARM Game® — an often used learning tool, highly regarded by top industry leaders.
